Document Detail


Prostate-specific antigen in clinical practice.
MedLine Citation:
PMID:  17258389     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Currently, in the United States (US), most prostate cancers are diagnosed through screening with digital rectal examination (DRE) and measurement of serum prostate-specific antigen (PSA). The serum PSA level correlates directly with prostate cancer risk and aggressiveness, as well as the outcomes after treatment. PSA testing is also useful in monitoring patients for tumor recurrence after treatment. PSA testing has limited specificity for prostate cancer detection, and its appropriate clinical application has been the topic of debate. Accordingly, several variations on the PSA measurement have emerged as useful adjuncts for prostate cancer screening. These take into consideration additional factors, such as the proportion of different PSA isoforms (free PSA, complexed PSA, pro-PSA and B PSA), the prostate volume (PSA density), and the rate of change in PSA levels over time (PSA velocity or PSA doubling time). Widespread PSA screening is associated with a 75% reduction in the proportion of men who present with metastatic disease since 1985-89 in the US and a 32.5% reduction in the age-adjusted prostate cancer mortality rate through 2003. The history and evidence underlying each of these parameters are reviewed in the following article.
Authors:
Stacy Loeb; William J Catalona
Related Documents :
11763389 - Lichen planus pigmentosus-inversus.
17327829 - Suicide gene therapy with adenoviral delivery of hsv-tk gene for patients with local re...
15126789 - Validation of increasing prostate specific antigen as a predictor of prostate cancer de...
19720449 - Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected...
19733959 - A risk-based strategy improves prostate-specific antigen-driven detection of prostate c...
16277989 - One-step immunostrip test for the simultaneous detection of free and total prostate spe...
11262979 - An nmr-based quenched hydrogen exchange investigation of model amyloid fibrils formed b...
22886669 - Colorectal cancers lack mitochondrial genomic instability.
23571149 - What influences the decision to participate in colorectal cancer screening with faecal ...
Publication Detail:
Type:  Journal Article; Review     Date:  2007-01-26
Journal Detail:
Title:  Cancer letters     Volume:  249     ISSN:  0304-3835     ISO Abbreviation:  Cancer Lett.     Publication Date:  2007 Apr 
Date Detail:
Created Date:  2007-03-23     Completed Date:  2007-06-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7600053     Medline TA:  Cancer Lett     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  30-9     Citation Subset:  IM    
Affiliation:
Department of Urology, Georgetown University School of Medicine, Washington, DC, United States.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Humans
Male
Prostate-Specific Antigen / blood*
Prostatic Neoplasms / blood,  diagnosis*
Chemical
Reg. No./Substance:
EC 3.4.21.77/Prostate-Specific Antigen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ureteral catheterization in uncomplicated ureterolithotripsy: a randomized, controlled trial.
Next Document:  TGF-beta-induced transcriptional activation of MMP-2 is mediated by activating transcription factor ...